Radioclinical Profile of Eosinophilic Lung: A Case Series.

Autor: Bouhamdi A; Pneumology Department, Hassan II University Hospital, Sidi Mohamed Ben Abdellah University, Fez, MAR., Saddouki F; Radiology Department, Hassan II University Hospital, Sidi Mohamed Ben Abdellah University, Fez, MAR., Alami B; Radiology Department, Hassan II University Hospital, Sidi Mohamed Ben Abdellah University, Fez, MAR., Serraj M; Pneumology Department, Hassan II University Hospital, Sidi Mohamed Ben Abdellah University, Fez, MAR., Biaz M; Pneumology Department, Hassan II University Hospital, Sidi Mohamed Ben Abdellah University, Fez, MAR., Benjelloun MC; Pneumology Department, Hassan II University Hospital, Sidi Mohamed Ben Abdellah University, Fez, MAR., Amara B; Pneumology Department, Hassan II University Hospital, Sidi Mohamed Ben Abdellah University, Fez, MAR.
Jazyk: angličtina
Zdroj: Cureus [Cureus] 2024 Jun 18; Vol. 16 (6), pp. e62579. Date of Electronic Publication: 2024 Jun 18 (Print Publication: 2024).
DOI: 10.7759/cureus.62579
Abstrakt: In this study, we present findings from an analysis of 17 patients diagnosed with eosinophilic lung disease, with a majority (64.70%) being male. The average age of the patients was 54 ± 13.22 years. A history of uncontrolled asthma was noted in nine cases. The clinical picture was characterized by persistent dyspnea and cough. Blood hypereosinophilia was present in all cases, with a median of 1770 cells/ul. Two patients had a pulmonary eosinophilia greater than 25%. Radiological findings were consistent with diffuse bilateral ground-glass opacities or areas of consolidation in the majority of cases. The main etiologies identified were chronic eosinophilic pneumonia (12 cases), followed by eosinophilic granulomatosis with polyangiitis (3 cases), idiopathic hypereosinophilic syndrome (1 case) and drug-induced hypereosinophilia (1 case). All patients were treated with systemic corticosteroids, with the addition of immunosuppressive therapy necessary in three cases. Notably, five relapses were recorded after corticosteroid therapy was stopped.
Competing Interests: Human subjects: Consent was obtained or waived by all participants in this study. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
(Copyright © 2024, Bouhamdi et al.)
Databáze: MEDLINE